is retatrutide legal ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide FDA Approval Status 2026:

Similar to the results observed with glucose administration, the hot plate test revealed a reduction in heat sensitivity after 1 h (Fig

key role of GLP-1R

The question of lifelong GLP-1 therapy does not have a universal answer, as treatment duration depends on the indication, individual patient circumstances, and treatment goals

As a result, potential safety concerns might arise in everyday clinical practice that were not evident during the more controlled and structured environment of clinical trial evaluations [Reference Paludetto, Olivier-Abbal and Montastruc28]

A large body of evidence has demonstrated that complete remission of type 2 diabetes can be achieved by a major weight loss

On social media, most of the microdosing chatter is about small amounts of weight loss, perceived (but not proven!) longevity benefits, and treating many forms of inflammation